Active Monitoring Promising for Women with Low-Risk Ductal Carcinoma In Situ By Ogkologos - January 8, 2025 858 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the COMET study Source RELATED ARTICLESMORE FROM AUTHOR Ovarian Reserve Better Indicator of Adjuvant Chemotherapy Benefit than Self-Reported Menopause Status, Age, or Other Hormone Levels Immune-Modulating SBRT Plus Anti-PD-L1 May Convert Immune-Cold ER-positive, HER2-negative EBC Into More Inflamed Tumours and Improve Response EMA Recommends Extension of Therapeutic Indications for Serplulimab MOST POPULAR New on NCI Websites for July 2019 July 2, 2019 How Wartime Violence Against Women Is Hurting Millions Worldwide August 2, 2021 Mom’s Early-Stage Breast Cancer Discovered When She Undergoes Testing to Donate... August 21, 2019 In the Name of Pinkness October 8, 2020 Load more HOT NEWS ‘Being open will help bring awareness’: Meet the fashion vlogger who... What to Know About Getting Access to New Cancer Advances Presented... Protective HPV Vaccine-Induced Antibody Titres Can Be Detected Up To 12... Born Blind With 50% Chance Of Survival, 20-Year-Old Musician Defied All...